Peptide & Nootropic Research

Partial AR agonist cutting SARM — known for yellow vision side effect at high doses.

Rev-Erbα agonist exercise mimetic — +50% endurance in mice. Poor oral bioavailability.

Mild partial SARM — lower binding affinity, potentially fewer side effects than RAD/LGD.

Potent full AR agonist SARM — more suppressive than LGD-4033. Advanced compound.

Partial AR agonist — 66% anabolic / 27% androgenic ratio. Milder SARM option.

Esterified RAD-140 — benzoate ester extends half-life and stability.

Selective PPARδ agonist — next-gen cardarine for endurance and fat oxidation.

Hexapeptide GH secretagogue — 100-300mcg 2-3x daily, ~7.5x GH peak. Compared with GHRP-6 and Ipamorelin.

Off-label 1-4.5mg protocol. Endorphin upregulation, TLR4 modulation, autoimmune applications.

NGF and BDNF support, cognitive function research, nerve-regeneration studies.

High-dose B1 for neurodegeneration and brain health — Costantini protocol with clinical citations.

Dopamine precursor — military-tested cognitive performance under stress, dosing and timing.

On-demand SSRI for premature ejaculation. 30-60mg 1-3hr pre-activity, efficacy vs alternatives.

The safe blood sugar spice — Ceylon vs Cassia coumarin, glucose data, daily supplementation safety.

Rev-Erbα agonist — exercise mimetic, metabolic research, compared with Cardarine and MK-677.

Historical and modern psychedelic protocols — cultural, pharmacological, contemporary research.

How GLP-1 weight loss affects lean mass, mitigation protocols, and what the trials show about sarcopenia risk.

Khavinson's tetrapeptide. Telomerase activation, pineal gland regulation, 25+ years of Russian longevity research.

40:1 myo:D-chiro ratio, 4g/day. Matches metformin for PCOS insulin sensitivity with far fewer side effects. Strong fertility + IVF data.

Eugeroic for narcolepsy and shift-work. Strongest cognitive effects in sleep-deprived states; Limitless-narrative oversold for rested users.

BPC-157 alone isn't enough — a 4-pathway protocol with KPV, L-glutamine, zinc-carnosine, butyrate, curcumin.

Phase 2 trial: up to 24.2% weight loss in 48 weeks — the triple agonist data visualized.

Why retatrutide is 55% more effective than semaglutide — not "slightly better." Triple receptor agonist comparison.

Clinical weight loss results by week, by dose. Real data — not anecdotes.

Complete Phase 2 safety data (N=338). GI rates by dose, severity, and comparisons.

Next-gen triple agonist (GLP-1/GIP/glucagon). Up to 24% body weight loss in trials. Dosing, timeline, and safety.

How GLP-1 agonists improve metabolic health BEFORE weight loss. Acanthosis nigricans, beta cell protection, food noise.

5 next-gen weight loss drugs: orforglipron (oral), cagrisema, survodutide, pemvidutide, mazdutide. 20%+ weight loss, dual agonists.

The original GLP-1 agonists compared: daily vs weekly, SCALE/LEADER vs AWARD/REWIND trials, 8% vs 4% weight loss, when older GLP-1s are still the right choice.

Why most peptides must be injected. The semaglutide pill exception. Which ultra-short peptides survive digestion.

SURMOUNT-1 trial: up to 20.9% weight loss. Mounjaro/Zepbound data breakdown.

STEP 1 clinical trial: 14.9% average weight loss over 68 weeks. Ozempic/Wegovy data.

Dual GIP/GLP-1 vs GLP-1 only. SURMOUNT vs STEP: 22.5% vs 15.8% weight loss, A1C, dosing, cost compared.

Every Ozempic alternative compared — tirzepatide, retatrutide, compounded semaglutide, oral GLP-1s, and natural options.

Why your semaglutide stopped working — dose issues, metabolic adaptation, diet drift — and evidence-based fixes.

6 weight loss peptides ranked by evidence: semaglutide, tirzepatide, retatrutide, tesamorelin, CJC/Ipa, AOD-9604.

10-compound tissue regeneration protocol: GLOW blend, bioregulators, gut restoration, immune activation.

BPC-157 + TB-500, GHK-Cu combos, and full recovery protocols. Dosing schedules, synergy mechanisms, and monthly cost breakdowns.

The 4-peptide recovery stack: GHK-Cu + KPV + BPC-157 + TB-500. Synergistic repair pathways visualized.

What 544 studies actually show about healing, gut protection, and musculoskeletal repair.

Human study: 11/12 patients got significant relief from a single injection lasting 6-12 months.

Spinal cord injury recovery, neuroprotection for sciatica, and disc healing mechanisms — research breakdown.

Rotator cuff recovery in animal models, tendon healing mechanisms, and extrapolation from knee study data.

Modified BPC-157 built for oral delivery. Why it's trending post-FDA crackdown, evidence review, and honest dosing guidance.

Thymosin Beta-4: 544+ studies on tissue repair, inflammation, and recovery — honest assessment.

72 biological actions, 4,000+ genes. Copper tripeptide delivery comparison — proven topical vs controversial injectable.

The Janoshik standard, LCMS testing, purity explained, CoA reading guide, and heavy metals myth-busting.

Two healing peptides compared: gut/tendon repair vs systemic tissue recovery. Mechanisms, dosing, stacking, and research status.

Fragment vs complete peptide — does TB-500 deliver the same results as full TB4? Mechanisms, clinical evidence, and when the complete protein matters.

Peptide Sciences closed March 6, 2026. The FDA reclassified 14 peptides to Category 1. Your complete guide to the two paths forward.

BPC-157, TB-500, GHK-Cu ranked by evidence strength. Mechanisms, dosing, and combination protocols.

The 3-amino acid anti-inflammatory tripeptide. Oral bioavailability, gut healing, and NF-κB inhibition.

Human cathelicidin — innate immune defense. Antimicrobial, wound healing, biofilm disruption.

Injection vs oral vs nasal spray — bioavailability comparison, when to use each route, and practical dosing.

Complete guide to oral BPC-157 for IBS, IBD, leaky gut, ulcers, gastritis, and GERD. Dosing and protocols.

Honest assessment of angiogenesis risks, cancer considerations, and what the research actually shows about long-term use.

Combination protocol for joint pain and arthritis. Dosing, injection sites, stacking schedule, and expected timeline.

GHRH (1-29) analog: pulsatile GH release, IGF-1 data, sleep effects, and comparisons vs HGH, ipamorelin, CJC-1295, tesamorelin.

FDA-approved since 1985. $500-3000/mo cost, 1-2 IU anti-aging dose, risks include insulin resistance and joint pain.

Oral GH secretagogue (not a peptide). ~40% IGF-1 increase, 10-25mg daily, 24hr half-life.

Strongest appetite stimulation of all GHRPs. Used for wasting conditions. ~6x GH increase.

FDA-approved GHRH analog for visceral fat loss and anti-aging. GH release, body composition data, and clinical protocols.

The most popular GH secretagogue stack. GHRH analog + selective GHRP = amplified GH pulse. Teichman 2006 DAC data, Raun 1998 selectivity, dosing protocols.

Most potent synthetic GHRP. Unique CD36 cardioprotection. Produces largest GH pulses but elevates cortisol/prolactin. 2-4 week cycle only.

Hexarelin vs GHRP-2 vs GHRP-6 vs Ipamorelin: complete comparison of ghrelin receptor agonists. GH pulse data, selectivity, side effects, dosing protocols.

Dehydroepiandrosterone — declines 80% by age 70. 25-50mg dosing, OTC since 1994.

Fertility and TRT adjunct. 250-500 IU 2x weekly. FDA compounding changed in 2020.

SERM for testosterone — raises T ~175% without shutdown. 12.5-25mg oral.

0.5-2mg estradiol, 100-200mg progesterone. WHI study context and current guidelines.

What to test, how to read your results, and why "normal" isn't the same as optimal. Complete panel guide.

Complete testosterone research — from diagnosis to protocols. TRT, enclomiphene, HCG, and more.

Everything about testosterone replacement therapy — protocols, bloodwork, side effects, and results.

Essential after any suppressive SARM or hormone cycle. HPG axis recovery, SERM protocols, bloodwork guide.

Head-to-head comparison of the 3 testosterone treatment paths — T levels, fertility, cost, and reversibility.

Estrogen management on TRT — when you need an AI, when you don't, and how not to crash your E2.

The complete biohacker stack — CJC/Ipa, BPC-157, HCG, MK-677, GHK-Cu. Protocols, bloodwork, and costs.

Therapeutic uses, nasal spray vs injection dosing, social bonding, and clinical research on the "love hormone."

FDA-approved melanocortin receptor agonist for HSDD. Phase III clinical data, mechanism review, and dosing protocols.

All 11 Khavinson bioregulators: dosing, stacking protocols, cycling guide, and oral bioavailability.

Neuroprotection tripeptide. 72 TBI patients, 59.4% memory improvement, sleep architecture optimization.

BBB-crossing tripeptide guide: serotonin/melatonin modulation, Khavinson family context, dosing protocols, and who it's for.

Brain anti-aging peptide — neuroprotection, cognitive enhancement, and practical dosing guide.

The complete Khavinson protocol: Epitalon + Pinealon + Vilon + Vesugen stacking and cycling guide.

The Russian longevity duo — neuroprotection + telomere maintenance + circadian optimization in one pulsed protocol.

28-amino-acid thymic peptide. Approved as Zadaxin in 30+ countries. Enhances T cells, NK cells, dendritic function, and unmasks senescent cells.

First mitochondrial-derived peptide (2001). Anti-apoptotic, neuroprotective, declines 40% with age. Alzheimer's and metabolic syndrome research.

24-amino acid peptide from mtDNA. Cytoprotective, anti-apoptotic, insulin-sensitizing. Research in Alzheimer's, diabetes, cardiovascular.

16-amino acid mtDNA-encoded peptide. Activates AMPK, promotes metabolic homeostasis, enhances exercise capacity. Levels decline ~50% with age.

16-amino acid "exercise mimetic" peptide. Activates AMPK, improves glucose metabolism. Pinchas Cohen lab (USC).

Tetrapeptide targeting cardiolipin. Phase 3 trials for Barth syndrome, heart failure, AMD. Larimar Therapeutics.

Deep-dive: Phase 2/3 results, cardiolipin-binding mechanism, pharma pipeline story, safety profile, and mitochondrial dysfunction context.

Three-layer energy system: NAD+ (fuel), MOTS-c (biogenesis signal), 5-Amino-1MQ (NAD+ preserver). Fix the engine, not the gas pedal.

Lipophilic thiamine for gut/autonomic support, POTS, and heavy metal chelation. Paradox reaction guide and cofactor protocol.

The only dopaminergic thiamine — upregulates D1 receptors for motivation and cognition. Cycling protocol required.

3-tier protocol: Foundation → Optimization → Advanced. 10 compounds, cycling calendar, interaction warnings.

10-compound protocol for cognitive preservation: thiamine, lion's mane, bacopa, alpha-GPC, omega-3, CDP-choline, NAC, methylene blue, CoQ10, bromantane.

FDA uses, cognitive enhancement research, mechanism, dosing, and military studies.

Soviet actoprotector: dual dopamine + serotonin synthesis. The "want to work" drug. WADA banned 1996.

Latvian carnitine inhibitor: shifts cells to oxygen-efficient glucose metabolism. Caught Sharapova. WADA banned 2016.

Fat-soluble B1 with 5-11x better absorption. Clinical trials on neuropathy, AGE reduction, and Alzheimer's.

Aniracetam, oxiracetam, pramiracetam, phenylpiracetam, and omberacetam compared.

Mandatory modafinil cofactor. Acetylcholine precursor + uridine source. CDP vs Alpha-GPC comparison.

Alpha wave promoter. Calm focus without sedation. The perfect stimulant companion — 200mg = 8 cups green tea.

Low-dose PDE5 inhibitor as cognitive enhancer. +15-25% cerebral blood flow. Stimulant vasoconstriction fix.

Glutathione precursor. Neuroprotection, addiction studies, liver guardian. Take before bed, never with stims.

Russian ACTH(4-10) analog. Upregulates BDNF 1.4x and NGF 2x. Approved in Russia for stroke recovery and cognitive impairment. Mechanism, clinical evidence, dosing, and Selank comparison.

Porcine brain-derived neuropeptide mixture. 200+ clinical studies. Approved in 40+ countries for stroke, TBI, and dementia. BDNF/NGF mimetic effects.

Russian anxiolytic neuropeptide (tuftsin analog). GABA-A allosteric modulation. Comparable to benzodiazepines without sedation or dependence. Approved Russia 2009. Dosing, mechanism, clinical evidence.

9-amino acid neuropeptide for deep sleep. Promotes delta-wave sleep, modulates stress response and pain. Pairs well with Selank. Research, protocols, and safety.

Nootropic stacking for sustained flow states. Compounds, timing, and the neuroscience of deep work.

Clinical trial data on NMN, NR, and NAD+. What the science supports — and what it doesn't.

140-year-old drug reimagined as a nootropic. Mechanisms, neuroprotection, dosing, and the blue tongue test.

Complete breakdown of both Huberman Lab peptide episodes — BPC-157, GH secretagogues, GLP-1s, and risks.

Synaptogenesis peptide with extraordinary in vitro potency. HGF/c-Met pathway, animal data only, fosgonimeton Phase 2 connection, cancer risk analysis.

Hexapeptide 10M× BDNF potency. HGF/c-Met activator. Very limited research — high uncertainty.

Porcine brain peptide mixture. 200+ clinical studies, approved in 40+ countries. IV/IM only.

Russian cognitive enhancer. 1000× piracetam potency. AMPA/NMDA modulation, BDNF increase.

FDA banned CNS stimulant — 25-75mg. Hemorrhagic stroke risk, cardiac events. Jack3d history.

DMAA successor in pre-workouts. FDA warning letters issued. CNS stimulant — 100-200mg.

Ayurvedic memory herb — bacosides improve memory acquisition and reduce anxiety. Takes 8-12 weeks to work.

Most bioavailable choline source — boosts acetylcholine, supports cognition, 14% power output increase in athletes.

DHA makes up 40% of brain PUFAs. VITALITY-BRAIN trial, MIDAS study, REDUCE-IT. Dosing for cognitive longevity and cardiovascular protection.

β-Carboline alkaloid — upregulates TH, BDNF, GDNF, and 8+ neurotrophic factors in animal models. Dopamine restoration research chemical. MAO inhibitor. No human trials. Photosensitive.

HGH fragment (177-191) for fat loss. Stimulates lipolysis without IGF-1 effects. TGA approved in Australia.

Myostatin inhibitor. Gene therapy research, "Schwarzenegger mice" with 2-3x muscle mass. Extremely expensive.

Synthetic α-MSH for UV-free tanning. Developed at U of Arizona. Precursor to PT-141. Side effects: nausea, flushing.

NNMT inhibitor for fat loss. Very new — only mouse data. Oral bioavailability. University of Texas research.

Preclinical research on ivermectin's anti-glioblastoma effects — Akt/mTOR inhibition, apoptosis pathways, and study limitations.

Alternative cancer protocol: fenbendazole, mebendazole, FECO, methylene blue, TUDCA, activated charcoal. Evidence review.

Dr. William Makis experimental cancer approach: ivermectin, fenbendazole, mebendazole dosing and supplements. Heavily disclaimed.

ARB with PPAR-γ agonism — blood pressure control plus metabolic benefits.

Cardioselective beta blocker with NO-releasing vasodilation. Preferred for athletes.

Most potent statin — reduces LDL 50-63%. JUPITER trial: 44% CV risk reduction.

Cholesterol absorption inhibitor — stacks with statins. IMPROVE-IT trial data.

Triple reuptake inhibitor — 10-13% body weight loss in Phase 3. Not approved in US.

Peptidomimetic targeting fat vasculature — 11% weight loss in primates. Experimental.

85% cure rate for severe acne. 0.5-1mg/kg/day x 15-20 weeks. iPLEDGE, liver monitoring.

Cyanocobalamin vs methylcobalamin, 1000mcg IM weekly protocol, bypasses GI absorption.

Cosmetic anti-wrinkle octapeptide that modulates SNARE complex to reduce expression lines up to 63%.

FDA-approved 5α-reductase inhibitor. Blocks DHT by 70%. 83% stop hair loss. Gold standard oral treatment since 1997.

FDA-approved vasodilator for hair growth. Topical and oral protocols. 40% responder rate. OTC since 1996.

Experimental topical antiandrogen. NOT FDA-approved. Limited human data. Development abandoned 1990s. Use with caution.

Potassium channel opener — OTC hair regrowth. Topical or oral low-dose options.

Topical anti-androgen research chemical — blocks DHT at follicle. No human trials.

Mechanisms, age-related decline data, FDA-approved formulations, dosing protocols, lab monitoring, side effects, and TRAVERSE trial safety data.

Pulsatile GnRH analog that preserves HPTA on TRT. ~70% testosterone normalization. Fertility-preserving alternative to hCG.

Emerging fertility treatment that stimulates LH pulses without receptor desensitization. IVF and hypogonadism applications.

Deep research infographic on kisspeptin's HPG axis role, Imperial College IVF trials (~95% oocyte maturation, ~90% OHSS reduction), and fMRI brain studies.

GnRH agonist for prostate cancer and controversial 'PCT reset' single-dose protocol. Initial LH surge then suppression.

Human Menopausal Gonadotropin — direct FSH/LH for hypogonadotropic hypogonadism and assisted reproduction.

Gold standard SERM for PCT. Raises LH 55%, restores testosterone in 75-85%. 20-40mg dosing protocols.

Best SERM for gynecomastia — 86% response vs 41% tamoxifen. Bone-protective. 60mg daily.

Most prescribed AI for TRT. Suppresses E2 80-90%. 0.5-1mg weekly. Reversible aromatase inhibitor.

Steroidal AI with irreversible binding. No E2 rebound. Better lipids. Take with fat.

99%+ E2 suppression. Off-label fertility use (first-line PCOS). Easy to crash estrogen.

SERM for PCT and breast cancer — blocks estrogen receptors, stimulates LH/FSH.

SERM for gynecomastia reversal — 91% improvement. Better side effects than tamoxifen.

Non-steroidal AI — 80-90% estrogen reduction. Most common on-cycle estrogen control.

Suicidal aromatase inhibitor — irreversible, no estrogen rebound. Mildly androgenic.

Strongest AI available — >99% estrogen suppression. Also used for ovulation induction.

GnRH analog for fertility preservation on TRT — maintains testicular function and LH/FSH.

Upstream GnRH stimulator — emerging IVF trigger with ~95% oocyte maturation, reduced OHSS.

GnRH agonist for PCT reset and prostate cancer — initial surge then suppression.

Direct FSH+LH gonadotropin — ~68% sperm recovery. Rx fertility drug.

PDE5 inhibitor — FDA-approved for ED and PAH. 69% response rate at 50mg.

5α-reductase inhibitor — blocks 65% of DHT. 83% maintain hair at 2 years.

Most prescribed US drug. Prohormone converts to T3. Dosing 1.6mcg/kg. Brand vs generic debate.

Active thyroid hormone. 4-5× more potent than T4. Half-life ~1 day. Combination therapy debate.

Natural desiccated thyroid. Contains T4+T3+T2+T1+calcitonin. Patient preference vs synthetic.

Foundation → Optimization → Advanced → Experimental. The pyramid of what to do first and why.

Everything Johnson does to reverse aging, visualized. Biomarkers, supplements, sleep, exercise, and the science.

40+ supplements: exact doses, timing, purpose, and a budget-friendly starter stack.

8 months of perfect sleep scores. The resting heart rate method, 10 habits, and the published research behind it.

mTOR inhibitor extends lifespan in every organism tested. 25% mice lifespan increase. Weekly dosing.

Sirtuin activator from red wine. David Sinclair's flagship compound. 70+ clinical trials.

Clearing zombie cells. Mayo Clinic research. Hit-and-run 3-day protocol.

10x more potent than quercetin. Found in strawberries. Mayo Clinic AFFIRM trial.

Beyond diabetes. AMPK activator. TAME trial targeting aging as the root cause.

Berberine, curcumin, cinnamon, ACV, and inositol — the complete natural alternative with protocols and bloodwork.

Nature's metformin — AMPK activation, blood sugar, lipids, dihydroberberine, and CYP3A4 drug interactions.

Anti-inflammatory powerhouse — NF-κB inhibition, bioavailability forms compared, joint and metabolic health.

Pre-meal blood sugar hack — reduces post-meal glucose 20-35%. Dosing, dilution safety, forms compared.

Insulin sensitizer for PCOS and metabolic health — the 40:1 ratio, fertility, anxiety, and dosing protocols.

20 frequently asked questions answered — basics, legality, reconstitution, side effects, specific compounds, sourcing, and costs.

Everything you need to know — what peptides are, the 5 categories, legal status, and how to get started safely.

Step-by-step guide to mixing peptides with BAC water. Ratios, math, common mistakes, and storage after mixing.

SubQ vs IM injection, needle gauge guide, site rotation diagram, pain management, and when to see a doctor.

Temperature, light, shelf life by peptide. Lyophilized vs reconstituted storage, travel tips, and degradation signs.

What's normal vs when to worry. Side effects by peptide category, GLP-1 nausea management, and red flags.

Reading COAs, HPLC chromatograms, mass spec basics, red flags, Janoshik testing, and vendor evaluation checklist.

What panels to order, when to test, and how to read results — for peptides, SARMs, TRT, GLP-1s, and all biohacker compounds.

Peptide reconstitution essential. 0.9% benzyl alcohol preservative, 28-day multi-dose shelf life. Not the same as sterile water.

Check compatibility for 15+ peptides. Timing recommendations, stacking scores, and popular pre-built stacks.

Track FDA approval status for 20 peptides. Pipeline visualization, trial phases, and key dates.

Build your peptide stack with interaction warnings, dosing, and cycling recommendations.

Most researched SARM. Phase 2/3 trial data. 3% lean mass gain at 3mg. Mild suppression, 24hr half-life.

1.21kg lean mass in 21 days at 1mg. Stronger than Ostarine, more suppressive. 36hr half-life.

Highest anabolic ratio (~90:1). Investigated for breast cancer. Neuroprotective in rodents.

NOT a SARM — PPARδ agonist. 68% endurance increase in mice. Cancer concern caused GSK to abandon.

Dual mechanism: SARM + myostatin inhibitor. Only cell study data exists. Steroidal structure.

Myostatin inhibitor — removes muscle growth brake. Gene therapy 2x mass, peptide SubQ much less. Safety concerns.

Strongest SARM. Male contraceptive research: 100% reversible infertility in rats. Very suppressive.

Post-cycle therapy after SARMs. HPG axis recovery in 4-8 weeks. Enclomiphene vs Nolvadex vs Clomid protocols.

17α-alkylated oral AAS. 20-50mg/day. Anabolic:androgenic 90-210:40-60. Hepatotoxic. PCT required.

East German Olympic doping drug. Oral, no aromatization. 20-50mg/day. Moderate liver toxicity.

Veterinary-origin injectable AAS. 300-600mg/week. Mild aromatization, increases RBC and appetite.

19× anabolic, 8.5× androgenic. Powerlifter pre-competition oral. Very hepatotoxic. 10-20mg/day.

Oral DHT derivative. Anti-estrogenic via SHBG binding. Enhances free testosterone. 25-75mg/day.

Injectable DHT derivative. Anti-estrogenic hardening agent. 300-500mg/week. No aromatization.

FDA-approved for hereditary angioedema. Oral/injectable cutting AAS. No aromatization. Hepatotoxic.

FDA-approved oral AAS. 20-80mg/day men, 2.5-10mg women. Anabolic:androgenic 322-630:24.

Very mild DHT-derivative AAS. 400-800mg/week injectable. Doesn't aromatize. Arnold's alleged favorite.

Most powerful oral AAS. 50-100mg/day. FDA-approved for anemia. Heavy hepatotoxicity, water retention.

Potent oral designer steroid. 10-20mg/day. Dry gains, extreme hepatotoxicity, banned by FDA 2012.

FDA-approved for anemia. Joint relief, collagen synthesis, 200-600mg/week. 19-nor progesterone issues.

Most powerful injectable AAS. 5× testosterone potency. Night sweats, tren cough, cardiovascular strain.

10× more potent than testosterone. 19-nor, male contraceptive research. TRT alternative research.

5α-reduced boldenone, no aromatization. Injectable 200-400mg/week. Very high PIP, dry gains.

17α-alkylated oral designer steroid banned under DASCA 2014. Hepatotoxicity, HPTA suppression.

Azine prodrug cleaving to methasterone in vivo. Extremely hepatotoxic oral designer steroid banned under DASCA 2014.

β2-adrenergic agonist for thermogenic fat loss. Not approved for humans in US. Cardiac risks, taurine depletion.

The first daily GLP-1 receptor agonist — SCALE Obesity, dosing, mechanism.

The original GLP-1 — derived from Gila monster venom in 1992.

Long-acting amylin analog. REDEFINE 1 hit 20.4% weight loss with semaglutide.

Boehringer's GLP-1/glucagon dual agonist — 19% weight loss, 83% MASH improvement.

First oral GLP-1 pill, FDA-approved Apr 2026

Mechanism, prevention, and reversibility of GLP-1 facial volume loss

Novo Nordisk's cagrilintide + semaglutide combo

Innovent's GLP-1/glucagon dual agonist — phase 3 GLORY data

Pfizer's discontinued oral GLP-1 — why the program died

Bonding peptide research — intranasal, social cognition, replication issues

cAMP-biased GLP-1 — Sciwind's phase-3 Lancet data

0.05–0.25 mg sub-therapeutic protocols and the evidence behind them

The longevity protein — 2026 human trials, AKL003 mRNA, Minicircle gene therapy

How Ozempic cuts drinking — JAMA Psychiatry RCT and 83K-patient cohort data

Zonulin antagonist for celiac and Long COVID — phase 2a 2026 readout

Oral vs injectable BPC-157: bioavailability, capsule formats, what works

2026 brand-by-brand comparison: cost, efficacy, coverage, who should pick what

Black-box warning, rodent vs human evidence, MTC contraindication, real risk picture

Post-shortage legal status, FDA crackdown, Hims/Hers DOJ probe, your options

PCAC reviews 7 peptides for the 503A bulks list — full agenda and outcomes guide

Veterinary BPC-157: vet-supervised dosing, hip dysplasia, ACL recovery, IBD

The 3-peptide recovery + skin combo vial — mechanism, dosing, vendor reality

Why no HGH pellet exists, what works (Sogroya weekly, secretagogues), Testopel comparison

Hip BMD loss data, tirzepatide HR 1.44, mitigation strategies for skeletal protection

Selank + Oxytocin + DSIP intranasal — mechanism, dosing, evidence reality check

When peptides need PCT vs cycling vs neither — per-class breakdown

Dogs, cats, horses: BPC-157, TB-500, oxytocin veterinary protocols

Bimagrumab, Trevogrumab, Apitegromab — the post-GLP-1 muscle-preservation drug class.

Preclinical gene-reset and VEGF-inhibition mechanisms for both peptides.

Why rapamycin and metformin failed in humans, and what muscle does that drugs cannot.

Six-peptide catastrophic-recovery protocol attributed to Jeremy Renner — Tα1, BPC-157, MOTS-c, Thymalin, Semax, Selank.

Why chronic dieters stall under 2,000 kcal and how retatrutide's glucagon arm may raise the metabolic ceiling.

What the evidence actually shows about combining intermittent fasting with semaglutide, tirzepatide, and retatrutide — risks, synergies, and the trials nobody has run.

Infographic map of the 10 peptide categories — every compound, every category, one guide.

Brain, bone, testosterone & addiction effects of retatrutide — the "soccer mom peptide" framing misses neuroprotection, synaptic preservation, bone formation, T support, and reward-circuit dampening.